AMGN broke out above 50 & 200-Day MAs on large Volume and is heading into a solid Resistance area around 58.
Biotech ETFs are very Bullish breaking above previous Resistance levels.
The relative performance charts of AMGN to the other S&P500 Biotech constituents is pointing to Outperformers: LIFE, GENZ & BIIB.
CELG & AMGN will have to overcome strong Resistance levels and GILD is clearly struggling.
Tidak ada komentar:
Posting Komentar